Upgrade to SI Premium - Free Trial

Form 3 PolyPid Ltd. For: Mar 18 Filed by: Missulawin Jonathan

March 23, 2026 4:01 PM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Missulawin Jonathan
(Last) (First) (Middle)
C/O POLYPID LTD.
18 HASIVIM STREET ISRAEL
(Street)
PETACH TIKVA 495376
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026 		3. Issuer Name and Ticker or Trading Symbol
PolyPid Ltd. [ PYPD ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock option (right to buy) 04/01/2017 03/08/2027 Ordinary Shares 20 (1) 123.01 D
Employee Stock option (right to buy) 02/02/2018 11/02/2027 Ordinary Shares 60 (2) 23.07 D
Employee Stock option (right to buy) 05/06/2020 02/06/2030 Ordinary Shares 16 (3) 23.07 D
Employee Stock option (right to buy) 06/11/2021 06/11/2030 Ordinary Shares 1,083 (4) 23.07 D
Employee Stock option (right to buy) 05/09/2023 05/09/2032 Ordinary Shares 1,167 (5) 23.07 D
Employee Stock option (right to buy) 08/09/2022 08/09/2031 Ordinary Shares 667 (6) 23.07 D
Employee Stock option (right to buy) 08/07/2024 08/07/2033 Ordinary Shares 10,000 (7) 11.01 D
Employee Stock option (right to buy) 08/06/2024 05/06/2034 Ordinary Shares 64,500 (8) 4.64 D
Employee Stock option (right to buy) 06/09/2025 05/06/2034 Ordinary Shares 43,000 (9) 4.64 D
Employee Stock option (right to buy) 08/12/2025 05/12/2035 Ordinary Shares 42,000 (10) 2.67 D
Employee Stock option (right to buy) 06/09/2025 05/12/2035 Ordinary Shares 28,000 (11) 2.67 D
Explanation of Responses:
1. The options were granted on March 8, 2017 and fully vested as of March 8, 2020.
2. The options were granted on November 2, 2017 and fully vested as of November 2, 2020.
3. The options were granted on February 6, 2020 and fully vested as of February 6, 2023.
4. The options were granted on June 11, 2020 and vest on a quarterly basis beginning September 11, 2021 until June 11, 2024.
5. The options were granted on May 9, 2022 and vest on a quarterly basis beginning August 9, 2023 until May 9, 2026.
6. The options were granted on August 9, 2021 and vest on a quarterly basis beginning November 9, 2022 until August 9, 2025.
7. The options were granted on August 7, 2023 and vest on a quarterly basis beginning November 7, 2024 until August 7, 2027.
8. The options were granted on May 6, 2024 and vest on a quarterly basis until May 6, 2028.
9. The options were granted on May 6, 2024 and vest on a quarterly basis until May 6, 2026.
10. The options were granted on May 12, 2025 and vest on a quarterly basis until May 12, 2029.
11. The options were granted on May 12, 2025 and vest on a quarterly basis until May 12, 2027.
/s/ Jonathan Missulawin 03/23/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Categories

SEC Filings